Completed PHASE4 INTERVENTIONAL NCT00077753

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization

Sponsor: Sanofi

Conditions Venous Thromboembolism

Interventions enoxaparin sodium

Updated 7 times since 2017 Last updated: Jan 10, 2011 Started: Feb 28, 2002 Primary completion: Oct 31, 2006 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00077753, this PHASE4 trial focuses on Venous Thromboembolism and remains completed. Sponsored by Sanofi, it has been updated 7 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Oct 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanofi

Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Berlin, Germany , Bogotá, Colombia , Bridgewater, United States , Brussels, Belgium , Buenos Aires, Argentina , Guildford, United Kingdom , Johannesburg, South Africa , Laval, Canada , Milan, Italy and 10 more locations